Generic Medicine Pharma
Generic Medicine Pharma
Paloxiron (Palonosetron) 0.5mg
Paloxiron (Palonosetron) 0.5mg
Paloxiron 0.5mg contains Palonosetron, a long-acting antiemetic used to prevent nausea and vomiting caused by chemotherapy and surgery. It works by blocking serotonin receptors and provides extended protection against nausea.
| Field | Details |
|---|---|
| Original Brand | Aloxi |
| Generic Brand | Paloxiron |
| Generic Name | Palonosetron 0.5mg |
| Pack Size | As per manufacturer packaging |
| Use / Indications | Chemotherapy-Induced Nausea, Postoperative Nausea and Vomiting |
| Manufacturer | Beacon Pharmaceuticals Ltd. (Bangladesh) |
| Status | Prescription Only Medicine |
Introduction to Aloxi (Palonosetron) 0.5mg
Paloxiron (Palonosetron) 0.5mg is a prescription medicine used to prevent nausea and vomiting caused by chemotherapy and surgery. It belongs to a class of medicines known as antiemetics, specifically serotonin (5-HT3) receptor antagonists, which work by blocking signals in the brain that trigger nausea and vomiting.
Paloxiron (Palonosetron) 0.5mg is classified under Prescription Medicines, Antiemetic Drugs, Oncology Supportive Care Medicines, and 5-HT3 Receptor Antagonists. It contains Palonosetron, which provides long-lasting protection against chemotherapy-induced nausea and vomiting (CINV).
In many markets, the original brand of Palonosetron is Aloxi, which contains the same active ingredient and offers similar therapeutic benefits when prescribed by a healthcare professional.
What Is Aloxi (Palonosetron)?
Aloxi is the original brand name for Palonosetron, an antiemetic medication widely used to prevent nausea and vomiting associated with chemotherapy and surgical procedures.
Palonosetron belongs to the class of serotonin (5-HT3) receptor antagonists. These medicines help block the action of serotonin, a natural substance that can cause nausea and vomiting.
Generic versions such as Paloxiron 0.5mg contain the same active compound and may be used based on physician recommendation and availability.
Drug Class and Mechanism of Action
Palonosetron is classified as a selective 5-HT3 receptor antagonist with antiemetic properties.
How Palonosetron Works
It works through the following mechanisms:
- Blocks serotonin (5-HT3) receptors in the brain and gut
- Prevents the vomiting reflex triggered by chemotherapy
- Provides prolonged anti-nausea effect due to long half-life
Through these mechanisms, Palonosetron effectively prevents both acute and delayed nausea and vomiting.
How Paloxiron Works in the Body
Chemotherapy and certain surgical procedures can release serotonin, which stimulates vomiting centers in the brain. Paloxiron helps prevent this response.
Key Actions of Palonosetron
- Inhibits serotonin activity in the central nervous system
- Prevents nausea signals from reaching the brain
- Provides long-lasting protection against vomiting
Generic versions like Paloxiron deliver the same active ingredient for effective supportive cancer care.
Medical Uses of Paloxiron (Palonosetron) 0.5mg
Paloxiron for Chemotherapy-Induced Nausea and Vomiting (CINV)
Paloxiron 0.5mg is primarily used to prevent nausea and vomiting caused by cancer chemotherapy.
Potential Benefits
- Prevents both acute and delayed nausea
- Improves patient comfort during cancer treatment
- Reduces need for additional antiemetic medicines
Paloxiron for Postoperative Nausea and Vomiting (PONV)
It is also used to prevent nausea and vomiting after surgery.
Treatment Benefits
- Reduces postoperative discomfort
- Helps faster recovery after surgery
- Improves overall patient experience
Who Can Take Paloxiron 0.5mg?
Eligibility Criteria
Patients may be prescribed Paloxiron if they:
- Are undergoing chemotherapy
- Are scheduled for surgery with risk of nausea
- Need preventive antiemetic therapy
Who Should Avoid Paloxiron (Palonosetron) 0.5mg
Paloxiron should NOT be used by:
- Patients allergic to Palonosetron
- Individuals with hypersensitivity to 5-HT3 antagonists
- Patients without medical supervision for chemotherapy-related care
Paloxiron (Palonosetron) 0.5mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- Paloxiron 0.5mg given before chemotherapy or surgery
- Administered as directed by a healthcare professional
- Usually given as a single dose per treatment cycle
Dosage Adjustments
Doctors may adjust the dose based on:
- Patient condition
- Type of chemotherapy
- Clinical response
Side Effects of Paloxiron 0.5mg
Common Side Effects
- Headache
- Constipation
- Fatigue
- Dizziness
Serious Side Effects
- Allergic reactions
- Irregular heartbeat (rare)
- Severe constipation
Patients should contact their doctor if serious symptoms occur.
Storage:
Store below 25°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.
Frequently Asked Questions (FAQs)
1. Is Paloxiron (Palonosetron) 0.5mg used for chemotherapy patients only?
It is mainly used for chemotherapy but can also be used for surgery-related nausea.
2. How long does Paloxiron work?
It has a long duration of action and can prevent nausea for up to 72 hours.
3. Is Paloxiron 0.5mg safe?
Yes, when used under medical supervision, it is generally safe and effective.
4. Can Paloxiron be taken daily?
It is usually given as a single dose before chemotherapy, not for daily use.
5. Does Paloxiron cause drowsiness?
It may cause mild dizziness or fatigue in some patients.
6. Is Paloxiron the same as Aloxi?
Paloxiron contains Palonosetron, the same active ingredient found in Aloxi.
7. Do I need a prescription for Paloxiron 0.5mg?
Yes, it is a prescription-only medicine.
Medical Disclaimer
Disclaimer:
This information is for educational purposes only and should not be considered medical advice. Paloxiron (Palonosetron) 0.5mg must be used under the supervision of a qualified healthcare professional. Always consult your doctor before using any medication.
